Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRANYLCYPROMINE vs TRASTUZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRANYLCYPROMINE vs TRASTUZUMAB: Safety Overview

Metric TRANYLCYPROMINE TRASTUZUMAB
Total FAERS Reports 386 46,537
Deaths Reported 38 5,564
Death Rate 9.8% 12.0%
Hospitalizations 132 13,839
Average Patient Age 54.4 yrs 56.3 yrs
% Female Patients 64.1% 91.7%
FDA Approval Date Apr 17, 2018 N/A
Manufacturer Solco Healthcare US, LLC Pfizer Laboratories Div Pfizer Inc
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription